Ameliorating effect of clentiazem (TA-3090), a new Ca antagonist, on the impaired learning ability of poststroke SHRSP
- 30 April 1995
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 50 (4) , 509-515
- https://doi.org/10.1016/0091-3057(94)00326-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of Clentiazem (TA-3090) with Posttreatment on Neurologic and Histologic Disorders of Stroke-Prone Spontaneously Hypertensive Rats with History of StrokeJournal of Cardiovascular Pharmacology, 1994
- Clentiazem protects against chronic cerebral vasospasm in rabbit basilar artery.Stroke, 1991
- Clentiazem reduces infarct size in rabbit middle cerebral artery occlusion.Stroke, 1991
- Nimodipine alters acquisition of a visual discrimination task in chicksBehavioral and Neural Biology, 1990
- S-emopamil ameliorates ischemic brain damage in rats: Histological and behavioural approachesLife Sciences, 1990
- NimodipineDrugs, 1989
- Hemodynamic comparison of diltiazem and TA-3090 in spontaneously hypertensive and normal Wistar-Kyoto ratsThe American Journal of Cardiology, 1988
- Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats.Stroke, 1988
- Prevention of postischemic hypoperfusion after canine cardiac arrest by nicardipineCritical Care Medicine, 1987
- Effect of nimodipine on intracellular brain pH, cortical blood flow, and EEG in experimental focal cerebral ischemiaJournal of Neurosurgery, 1986